SCHEMBL294199

SCHEMBL294199

OCCCCC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31077587 0.97 LMNA (0.38)
SCHEMBL292475 0.97 LMNA (0.38)
SCHEMBL31077494 0.97 LMNA (0.38)
SCHEMBL31077631 0.97 LMNA (0.38)
SCHEMBL2540704 0.97 LMNA (0.38)
SCHEMBL23014995 0.97 LMNA (0.38)
SCHEMBL29475240 0.97 LMNA (0.38)
SCHEMBL31077654 0.97 LMNA (0.38)
SCHEMBL18729648 0.97 SMN1; SMN2 (0.33)
SCHEMBL7850747 0.97 LMNA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250323319-A1 FLUORINATED ELECTROLYTE ADDITIVES E3TRIGEN, INC. (US) 2025-10-16 US claimed
WO-2025119223-A1 METHOD FOR SYNTHESIZING AMANITIN AND DERIVATIVE THEREOF 上海皓元生物医药科技有限公司 2025-06-12 WO claimed
CN-119242156-A High-toughness high-adhesion modified polyurethane building waterproof coating 天津联鑫高高分子科技发展有限公司 2025-01-03 CN claimed
US-20230348421-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) 2023-11-02 US claimed
CN-116585292-A Method for inducing anesthesia 加利福尼亚大学董事会 2023-08-15 CN claimed
WO-2023147513-A2 COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF WASHINGTON UNIVERSITY (US) 2023-08-03 WO claimed
EP-4186893-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Geneora Pharma (Shijiazhuang) Co., Ltd. (CN) 2023-05-31 EP claimed
US-20220384848-A1 FLUORINATED ELECTROLYTE ADDITIVES E3TRIGEN, INC. (US) 2022-12-01 US claimed
CN-114835620-A Application of alpha-diazoate and carboxylic acid ester-forming reaction in connection of polypeptide and modification of protein 南开大学 2022-08-02 CN claimed
EP-4032138-A1 FLUORINATED ELECTROLYTE ADDITIVES E3Trigen, Inc. (US) 2022-07-27 EP claimed
US-20120141817-A1 THIN METAL NANOWIRES PRODUCED BY BIOTEMPLATING MOROZOVA-ROCHE LUDMILLA (SE) 2012-06-07 US claimed
US-8143408-B2 N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain ASTRAZENECA AB (SE) 2012-03-27 US claimed
EP-2132013-B1 METHOD FOR THE MANUFACTURE OF THIN METAL NANOWIRES BY BIOTEMPLATING MOROZOVA-ROCHE LUDMILLA (SE) 2012-02-08 EP claimed
US-20100137322-A1 NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2010-06-03 US claimed
EP-2158198-A2 NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN AstraZeneca AB (SE) 2010-03-03 EP claimed
WO-2008130320-A2 NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO claimed
US-RE36617-E Anastrozole and salts as anticancer agent ZENECA LIMITED (GB) 2000-03-14 US claimed
EP-0296749-B1 (Substituted aralkyl) heterocyclic compounds ZENECA LTD (GB) 1994-10-26 EP claimed
US-4935437-A (Substituted aralkyl) heterocyclic compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-19 US claimed
EP-0296749-A1 (Substituted aralkyl) heterocyclic compounds ZENECA LIMITED (GB) 1988-12-28 EP claimed